Citations 250

Dopamine-responsive post-anoxic parkinsonism

Journal of Parkinson’s Disease | April 24, 2025 | Volume: 15 | Issue: 4 | Pages: 919-924

10.1177/1877718x251335044 | PMID 40270087

Background Parkinsonism following hypoxic ischemic damage of the basal ganglia is an uncommon phenomenon that has been infrequently reported. However, only a few cases have noted improvement of symptoms with dopaminergic therapy. We report the clinical and imaging features of five patients with post-anoxic parkinsonism responsive to dopamine supplementation. Objective To describe a retrospective case series of five cases of dopamine-responsive post-anoxic parkinsonism. Methods We identified all the cases using the Mayo Clinic Data Management System utilizing advanced data explorer search engine for any patients evaluated for post anoxic parkinsonism and its associated acronyms from 2000–2024. Clinical features, neuroimaging, medication trials, and responses were obtained from chart review of identified patients. Results Five patients met the inclusion criteria. All patients underwent anoxic events followed by development of parkinsonism. Patients exhibited parkinsonism described as combinations of bradykinesia, rigidity, tremor, and postural instability. All patients underwent evaluation by a neurologist, MRI imaging, and treatment by dopaminergic agents. Of the five patients, four received carbidopa/levodopa whereas one received a dopamine agonist. All patients were clinically followed for a median of approximately 4 years and showed improvement in parkinsonism. Conclusions Parkinsonism following a hypoxic ischemic insult is a rare occurrence but response to dopaminergic therapy in those cases is even more scarcely described. Our cases series provides important implications for treatment options for patients with post anoxic parkinsonism.
Pregnancy and delivery in women with Parkinson's disease: A case series

Journal of Parkinson’s Disease | April 13, 2025 | Volume: 15 | Issue: 4 | Pages: 913-918

10.1177/1877718x251316161 | PMID 40221966

Background Parkinson's disease (PD) is a progressive degenerative disease affecting people at any age; however, it is generally more prevalent in older age groups. Younger individuals, especially women, are facing significant challenges that pertain to pregnancy. Unfortunately, the available information is limited and supported mostly by anecdotical experience. Objective To gain insight into the interaction between early-onset PD and pregnancy. Methods We report on a case series of women, diagnosed with PD, that underwent pregnancy to explore the disease catachrestic, natural history, and different challenges associated with these unique group of people. Results We identified a total of 9 participants who met our inclusion criteria, who had gone through a total of 12 pregnancies after onset of PD motor symptoms. In 10 out of 12 pregnancies, participants did not use any PD medication; throughout 1 pregnancy, a participant used pramipexole and throughout 1 pregnancy, a participant used levodopa/carbidopa. Conclusions Our study supports the importance of further multicentric studies on pregnant women with PD to prospectively collect data on complications, birth outcomes, lactation, and PD severity.
Autonomic Impairment and Risk of Mortality in Early-Onset Parkinson Disease (S9.003)

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000210742

Clinical Characteristics of Juvenile Parkinson Disease in a Clinical Cohort (P9-5.015)

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000210739

Scans Without Evidence of Dopamine Deficiency (SWEDD) in Early Onset Parkinson’s Disease: Comparative Analysis (S32.009)

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000210717

Psychosis in Early Onset Parkinson’s Disease: A Population-based Study in Southeast Minnesota (P9-5.017)

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000211910

Clinical Utility of Skin Biopsy for Cutaneous Phosphorylated Alpha-synuclein in Cognitive Manifestations of Lewy Body Disease (P1-3.012)

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000211869

Autopsy-confirmed Neuropathological Disease in Sleep Disorders (P9-4.008)

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000211827

Patterns of Hypometablism on FDG PET in Patients with Early-onset Parkinson’s Disease and Psychosis (P3-5.018)

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000208936

Proximity to, and Presence of, Golf Courses on Vulnerable and Non-vulnerable Groundwater Service Areas and Risk of Parkinson Disease in a Population-based Study (P2-5.005)

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000209110